HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eva Allonca Selected Research

Nanog Homeobox Protein

7/2020Prognostic Significance of the Pluripotency Factors NANOG, SOX2, and OCT4 in Head and Neck Squamous Cell Carcinomas.
9/2019The Emerging Role of NANOG as an Early Cancer Risk Biomarker in Patients with Oral Potentially Malignant Disorders.
11/2017A Novel Role For Nanog As An Early Cancer Risk Marker In Patients With Laryngeal Precancerous Lesions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eva Allonca Research Topics

Disease

24Neoplasms (Cancer)
11/2020 - 08/2010
22Squamous Cell Carcinoma of Head and Neck
10/2021 - 08/2010
6Carcinogenesis
11/2020 - 08/2011
6Carcinoma (Carcinomatosis)
11/2020 - 08/2010
5Sarcoma (Soft Tissue Sarcoma)
11/2020 - 05/2016
5Neoplasm Metastasis (Metastasis)
11/2020 - 03/2013
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2020 - 08/2010
3Laryngeal Neoplasms (Laryngeal Cancer)
01/2018 - 08/2011
2Lymphatic Metastasis
07/2020 - 06/2013
2Mouth Neoplasms (Oral Cancer)
06/2013 - 07/2012
1Head and Neck Neoplasms (Head and Neck Cancer)
08/2019
1Pathologic Processes
02/2019
1Myxoid Liposarcoma
06/2017
1Tics (Tic)
05/2016
1Oral Leukoplakia
06/2013
1Disease Progression
08/2012
1Adenocarcinoma
01/2011

Drug/Important Bio-Agent (IBA)

12Proteins (Proteins, Gene)FDA Link
11/2020 - 08/2010
11Biomarkers (Surrogate Marker)IBA
04/2020 - 08/2010
5Cadherins (E-Cadherin)IBA
11/2020 - 03/2013
4Focal Adhesion Protein-Tyrosine KinasesIBA
01/2018 - 08/2011
3Messenger RNA (mRNA)IBA
11/2020 - 08/2010
3CateninsIBA
11/2020 - 03/2013
3Nanog Homeobox ProteinIBA
07/2020 - 11/2017
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2019 - 05/2016
3CortactinIBA
01/2018 - 08/2011
3Potassium Channels (Potassium Channel)IBA
07/2016 - 08/2010
3Annexin A2 (Annexin II)IBA
03/2014 - 01/2011
2PlicamycinFDA Link
08/2019 - 05/2016
2demycarosyl-3D-digitoxosylmithramycin SKIBA
08/2019 - 05/2016
2AnnexinsIBA
02/2019 - 01/2011
2Pharmaceutical PreparationsIBA
06/2017 - 05/2016
2Ribosomal Protein S6IBA
01/2017 - 05/2016
2Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA
07/2016 - 08/2012
2ParaffinIBA
08/2012 - 08/2010
1Cisplatin (Platino)FDA LinkGeneric
10/2021
1LectinsIBA
11/2020
1Cyclin D1IBA
11/2020
1SOXB1 Transcription FactorsIBA
10/2019
1src-Family KinasesIBA
08/2019
1saracatinibIBA
08/2019
1Dasatinib (BMS 354825)FDA Link
08/2019
1antineoplaston A10 (A 10)IBA
02/2019
1LigandsIBA
01/2019
1Phosphotransferases (Kinase)IBA
01/2019
1AntibodiesIBA
01/2019
1Alkylating AgentsIBA
06/2017
12- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
06/2017
1TrabectedinIBA
06/2017
1TOR Serine-Threonine KinasesIBA
01/2017
1Serine (L-Serine)FDA Link
01/2017
1Mechanistic Target of Rapamycin Complex 1IBA
05/2016
1EpitopesIBA
05/2015
1Monoclonal AntibodiesIBA
05/2015
1MucinsIBA
06/2013
1Glycoproteins (Glycoprotein)IBA
06/2013
1Ether (Diethyl Ether)IBA
08/2012
1Biological ProductsIBA
08/2012
1EnzymesIBA
12/2011
1Annexin A1IBA
01/2011
1Small Interfering RNA (siRNA)IBA
08/2010

Therapy/Procedure

3Therapeutics
11/2020 - 01/2019
1Radiotherapy
11/2020